Udac, Baby Boy .
HRN: 21-72-94 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/19/2022
08/25/2022
IVT
30
OD
PoTentially Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes